News
We would be genuinely pleased to discuss your project. So, if you have a particular need, please take a moment to fill in our contact form
L’offensive des CDMO – Passerelles IMT
GTP Nano & CEA validate an innovative manufacturing model for nanodrugs
Biomunex alongside Institut Curie and GTP Bioways awarded by the ‘Grand Défi Biomédicament’
![[In the press] Interview in Pharmaceutiques](https://wsi-ad2-gtp-refonte.alwaysdata.net/wp-content/uploads/2021/09/Alain_Sainsot_Pharmanetwork_V2-993x675.jpg)
[In the press] Interview in Pharmaceutiques
GTP Bioways invests €12M in two GMP biopharmaceutical production units
GTP Bioways in PHARMAnetwork to highlight the key role of CDMOs
Abionyx Pharma & GTP Bioways partnership highlighted
GTP Bioways acquires IDBiotech and expands its analytical expertise
Alain Sainsot, GTP Bioways’ CEO, interviewed in PHARMAnetwork
GTP Bioways – beginning of a new CDMO era
We offer customized solutions, contact us to discuss your project
GTP Bioways started providing custom recombinant protein production services in 2000 to accelerate biopharmaceutical development and overcome a wide range of challenges.
